Remember to subscribe to our Health Law Pulse blog to receive the latest updates on healthcare enforcement and regulations.
Stark and Anti-Kickback, the next frontier: An examination of the new Final Rules and their impact | Speakers: Stacey Murphy, Jeff Wurzburg, Joseph Keillor and Elise LeGros
Legal issues with infectious diseases: The good, the bad and the ugly | Speakers: Yvonne K. Puig, Kevin Mayer and Jackie Karama
View our pharma litigation team’s new 3-minute video series on legal updates relevant to pharmaceutical and medical device industries.
Publication
On 6 September 2022, the European Commission (EC or the Commission) prohibited Illumina’s acquisition of Grail, bringing to an end the administrative stage of a legal saga that has attracted interest beyond competition law specialists.
Subscribe and stay up to date with the latest legal news, information and events...
© Norton Rose Fulbright LLP 2022
